Jefferies lowered the firm’s price target on Molina Healthcare (MOH) to $160 from $162 and keeps a Hold rating on the shares. The firm calculates a 40 basis point year-over-year Medicaid MLR improvement in 2026 and sees the 2027 Medicaid MLR landing at 92.6% with rate updates closing 60%-65% of the rolling “insufficiency gap,” the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare upgraded to Buy from Hold at Nephron Research
- Cantor Fitzgerald says CMS guidance reinforces 2026 as ‘difficult for Medicaid’
- Republican lawmakers have yet to agree on healthcare plan, WSJ reports
- Trump Weekly: White House postpones healthcare proposal after backlash
- Trump Trade: White House postpones healthcare proposal after backlash
